An independent advisory panel of experts from the Centers for Disease Control and Prevention (CDC) on Tuesday, November 2, unanimously recommended a two-dose series of Pfizer-BioNTech COVID-19 vaccine for children ages 5-11. informs CNBC .
The vaccine will be given to children in smaller doses – 10 micrograms, which is one third of the amount that teenagers and adults receive.
CDC Director Rochelle Walenski signed a recommendation that allows vaccinations to start today.
Vaccination of children aged 5-11 is projected to reduce transmission of COVID-19 in the United States by 8% between November and March 2022.
According to the CDC, 1.9 million children aged 5 to 11 have suffered from COVID-19. However, the researchers did not find an increased risk of developing cardiac myocarditis as a result of vaccination.